Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer
Status:
Completed
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
This is a single-arm, interventional study aimed to observe the efficacy and safety of
Apatinib combined with S-1 for patients with advanced gastric cancer refractory to
oxaliplatin plus capecitabine combination therapy